Search Results

Zanubrutinib - Oral

… into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and for at … into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and for at …

Alemtuzumab Anti-Cancer - Injection

… into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended during treatment … into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended during treatment …

Sacituzumab Govitecan - Injection

… into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and for 1 month … into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and for 1 month …

Selpercatinib - Oral

… into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended while using this … into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended while using this …

Leuprolide Monthly 375 Mg - Intramuscular Injection

… into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug is not … into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug is not …

Diltiazem 24-Hour Sustained-Action Capsule - Oral

… breast milk and may have undesirable effects on a nursing infant. Consult your doctor before breast-feeding. Drug … breast milk and may have undesirable effects on a nursing infant. Consult your doctor before breast-feeding. Drug …

Palbociclib - Oral

… into breast milk. Because of the possible risk to the infant, breast-feeding during treatment and for at least 3 … into breast milk. Because of the possible risk to the infant, breast-feeding during treatment and for at least 3 …

Osimertinib - Oral

… into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended while using this … into breast milk. Because of the possible risk to the infant, breast-feeding is not recommended while using this …

Venetoclax - Oral

… into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and for 1 week … into breast milk. Because of the possible risk to the infant, breast-feeding while using this drug and for 1 week …

Rituximab - Subcutaneous Injection